ACADIA Pharmaceuticals, Inc. (ACAD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1149728,
    "name": "ACADIA Pharmaceuticals, Inc.",
    "stock_name": "ACADIA Pharmaceuticals, Inc.",
    "full_name": "ACADIA Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/acadia-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "26.55",
    "chg": 1.12,
    "chgp": "4.4%",
    "dir": 1,
    "prev_price": "25.43",
    "mcapval": "4,283.60",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US0042251084",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.62 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/acadia-pharmaceuticals-inc-1149728-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ACADIA Pharmaceuticals Hits Day Low of $20.03 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/acadia-pharmaceuticals-hits-day-low-of-2003-amid-price-pressure-3571231",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ACADIAPharmaceu_priceRelatedfactors_3571231.png",
        "date": "2025-09-25 16:35:37",
        "description": "ACADIA Pharmaceuticals, Inc. saw a significant decline in its stock today, reaching an intraday low. Despite this downturn, the company has demonstrated strong long-term performance, with notable increases over the past month and year. High institutional holdings and consistent positive results underscore its operational strength in the sector."
      },
      {
        "title": "Is ACADIA Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-acadia-pharmaceuticals-inc-technically-bullish-or-bearish-3547072",
        "imagepath": "",
        "date": "2025-09-20 19:46:26",
        "description": "As of 12 September 2025, the technical trend for ACADIA Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, and the monthly MACD is also bullish, indicating positive momentum. The daily moving averages are bullish, while the Bollinger Bands show a bullish stance on the weekly and mildly bullish on the monthly. However, the KST is mildly bearish on the weekly, which introduces some caution. \n\nIn terms of performance, ACADIA has outperformed the S&P 500 on a year-to-date basis with a return of 34.90% compared to the S&P 500's 12.22%, and it has also significantly outperformed over the past year with a return of 51.59% versus 17.14%. However, over the longer term, it has underperformed the S&P 500 in both the 3-year and 5-year periods. Overall, the current technical stance is mildly bullish, supported by several positive indicators, but tempered by mixed signals i..."
      },
      {
        "title": "Is ACADIA Pharmaceuticals, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-acadia-pharmaceuticals-inc-overvalued-or-undervalued-3543507",
        "imagepath": "",
        "date": "2025-09-20 18:21:16",
        "description": "As of 6 August 2025, the valuation grade for ACADIA Pharmaceuticals, Inc. has moved from very attractive to attractive. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 16, an EV to EBIT of 34.05, and an EV to EBITDA of 29.59, which are higher than some of its peers, such as Exelixis, Inc. with a P/E of 15.81 and Alkermes Plc with an EV to EBITDA of 9.41.\n\nIn comparison to the S&P 500, ACADIA has shown strong one-year returns of 51.59%, significantly outperforming the index's 17.14%. However, over a three-year period, it lags behind the S&P 500, which returned 70.41%, indicating potential concerns about long-term growth. Overall, the current valuation suggests that investors may be paying a premium for ACADIA Pharmaceuticals, Inc. relative to its peers and historical performance...."
      },
      {
        "title": "ACADIA Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/acadia-pharmaceuticals-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-stock-price-increase-3522732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ACADIAPharmaceu_technicaldot_3522732.png",
        "date": "2025-09-16 18:37:27",
        "description": "ACADIA Pharmaceuticals, Inc. has recently revised its evaluation amid changing market dynamics. The stock has shown strong performance over the past year, significantly outperforming the S&P 500. Technical indicators present mixed signals, reflecting both bullish and bearish trends in the short term."
      }
    ],
    "total": 10,
    "sid": "1149728",
    "stock_news_url": "https://www.marketsmojo.com/news/acadia-pharmaceuticals-inc-1149728"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

ACADIA Pharmaceuticals Hits Day Low of $20.03 Amid Price Pressure

2025-09-25 16:35:37

ACADIA Pharmaceuticals, Inc. saw a significant decline in its stock today, reaching an intraday low. Despite this downturn, the company has demonstrated strong long-term performance, with notable increases over the past month and year. High institutional holdings and consistent positive results underscore its operational strength in the sector.

Is ACADIA Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:46:26

As of 12 September 2025, the technical trend for ACADIA Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, and the monthly MACD is also bullish, indicating positive momentum. The daily moving averages are bullish, while the Bollinger Bands show a bullish stance on the weekly and mildly bullish on the monthly. However, the KST is mildly bearish on the weekly, which introduces some caution. In terms of performance, ACADIA has outperformed the S&P 500 on a year-to-date basis with a return of 34.90% compared to the S&P 500's 12.22%, and it has also significantly outperformed over the past year with a return of 51.59% versus 17.14%. However, over the longer term, it has underperformed the S&P 500 in both the 3-year and 5-year periods. Overall, the current technical stance is mildly bullish, supported by several positive indicators, but tempered by mixed signals i...

Is ACADIA Pharmaceuticals, Inc. overvalued or undervalued?

2025-09-20 18:21:16

As of 6 August 2025, the valuation grade for ACADIA Pharmaceuticals, Inc. has moved from very attractive to attractive. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 16, an EV to EBIT of 34.05, and an EV to EBITDA of 29.59, which are higher than some of its peers, such as Exelixis, Inc. with a P/E of 15.81 and Alkermes Plc with an EV to EBITDA of 9.41. In comparison to the S&P 500, ACADIA has shown strong one-year returns of 51.59%, significantly outperforming the index's 17.14%. However, over a three-year period, it lags behind the S&P 500, which returned 70.41%, indicating potential concerns about long-term growth. Overall, the current valuation suggests that investors may be paying a premium for ACADIA Pharmaceuticals, Inc. relative to its peers and historical performance....

ACADIA Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-09-16 18:37:27

ACADIA Pharmaceuticals, Inc. has recently revised its evaluation amid changing market dynamics. The stock has shown strong performance over the past year, significantly outperforming the S&P 500. Technical indicators present mixed signals, reflecting both bullish and bearish trends in the short term.

View All News